Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9862858 | 0.89 | MEN1 (0.44) | MEN1KMT2ATDP1 | |
| SCHEMBL10410249 | 0.87 | MEN1 (0.38) | MEN1KMT2ATDP1 | |
| SCHEMBL1066191 | 0.82 | — | — | |
| SCHEMBL1279347 | 0.79 | — | — | |
| SCHEMBL10538153 | 0.79 | MEN1 (0.35) | MEN1KMT2ATDP1 | |
| SCHEMBL1279732 | 0.78 | — | — | |
| SCHEMBL10489528 | 0.77 | — | — | |
| SCHEMBL25327648 | 0.77 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL1279986 | 0.77 | MEN1 (0.50) | MEN1KMT2ATDP1 | |
| SCHEMBL144465 | 0.77 | MEN1 (0.50) | MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024223620-A1 | NOVEL USES OF FLUOROCARBONS | Midas Pharma GmbH (DE) | 2024-10-31 | — | — | WO | claimed |
| EP-4454743-A1 | NOVEL USES OF FLUOROCARBONS | Midas Pharma GmbH (DE) | 2024-10-30 | — | — | EP | claimed |
| US-20230017661-A1 | COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE DELIVERY OF VARIOUS AGENTS AND USE THEREOF | VERI NANO INC. (US) | 2023-01-19 | — | — | US | claimed |
| CN-115531302-A | Ophthalmic composition for treating corneal angiogenesis disorders | 江苏君隽生物科技有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115487305-A | Liquid composition for delivering active pharmaceutical ingredients | 江苏君隽生物科技有限公司 | 2022-12-20 | — | — | CN | claimed |
| US-20210283071-A1 | PREPARATION OF A SINGLE-SURFACTANT MICROEMULSION | The Rosano Family Irrevocable Trust of 2015 (US) | 2021-09-16 | — | — | US | claimed |
| WO-2021119464-A1 | COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE DELIVERY OF VARIOUS AGENTS AND USE THEREOF | VERI NANO INC. (US) | 2021-06-17 | — | — | WO | claimed |
| US-20190151220-A1 | DERMAL REJUVENATION COMPOSITIONS AND METHODS | Kate Somerville Skincare, LLC (US) | 2019-05-23 | — | — | US | claimed |
| EP-2744519-B1 | DERMAL REJUVENATION COMPOSITIONS | KATE SOMERVILLE SKINCARE LLC (US) | 2018-10-03 | — | — | EP | claimed |
| US-20170367959-A1 | DERMAL REJUVENATION COMPOSITIONS AND METHODS | Kate Somerville Skincare, LLC (US) | 2017-12-28 | — | — | US | claimed |
| US-20020068860-A1 | Implantable glucose sensor | IMPLANTED BIOSYSTEMS, INC. | 2002-06-06 | — | — | US | claimed |
| US-6343225-B1 | SENSOR PROVIDING OXYGEN RESERVOIR IN INTIMATE CONTACT WITH OXIDATIVE ENZYME BY MAKING EMULSION OF ENZYME AND COMPOUND IN WHICH OXYGEN IS EXTREMELY SOLUBLE AND STABILIZING BY CROSSLINKING MIXTURE TO FORM GEL | IMPLANTED BIOSYSTEMS, INC. | 2002-01-29 | — | — | US | claimed |
| WO-2001020019-A2 | IMPLANTABLE GLUCOSE SENSOR | IMPLANTED BIOSYSTEMS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| EP-0722313-B1 | VISCOELASTIC COMPOSITIONS OF FLUORINATED ORGANIC COMPOUNDS | ALLIANCE PHARMA (US) | 1999-05-12 | — | — | EP | claimed |
| US-5573757-A | TOPICAL GEL | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-11-12 | — | — | US | claimed |
| EP-0722313-A1 | VISCOELASTIC COMPOSITIONS OF FLUORINATED ORGANIC COMPOUNDS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-07-24 | — | — | EP | claimed |
| WO-1995009606-A1 | VISCOELASTIC COMPOSITIONS OF FLUORINATED ORGANIC COMPOUNDS | ALLIANCE PHARMACEUTICAL CORP. (US) | 1995-04-13 | — | — | WO | claimed |
| US-4968358-A | STRESS RELIEVING, TRANSFERRING HEAT OF CONDENSATION TO ALLOY | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1990-11-06 | — | — | US | claimed |
| US-4940072-A | HEATING IN PRESENCE OF FLUOROCARBON VAPOR WHICH CONDENSES ON PATTERN AND MELTS IT | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1990-07-10 | — | — | US | claimed |
| US-4929283-A | Vapor phase artificial aging of metal alloys using fluorochemicals | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1990-05-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230017661-A1 | COMPOSITIONS AND MODULAR NANO- AND MICROPARTICLES FOR THE DELIVERY OF VARIOUS AGENTS AND USE THEREOF | CD47, CD44, CHMP4B | MEN1 731/4885KMT2A 3696/4885TDP1 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.